The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History
Clinical Lymphoma Myeloma and Leukemia · 2026
DOI: 10.1016/j.clml.2025.10.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026. Verfasst von Yaşa Gül Mutlu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Gaziantep City Hospital, Gaziantep, Turkey. Electronic address: yasagulmutlu@hotmail.com. Hauptthemen laut MEDLINE: Multiple Myeloma, Neoplasms, Multiple Primary. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The coexistence of solid tumors and multiple myeloma (MM) presents diagnostic and therapeutic challenges; however, data on clinical outcomes in this population remain limited. This study aimed to evaluate the clinical characteristics and survival outcomes of patients with newly diagnosed multiple myeloma (NDMM) who had synchronous or prior solid tumor malignancies. METHODS: A retrospective analysis was conducted on 41 NDMM patients with a documented history of solid tumor, classified as either concurrent (diagnosed within 6 months) or prior. Clinical characteristics, treatment patterns, and outcomes were evaluated. Patients were stratified according to the timing of solid tumor diagnosis. RESULTS: The median age was 66 years, with a male predominance (58.5%). Breast (24.4%), lung (17.1%), colon, and prostate cancers (9.8% each) were the most common solid tumors. Extramedullary disease was observed only in the synchronous group (100% vs. 0%). Autologous transplantation was performed significantly less frequently in the synchronous group (26.3% vs. 73.7%, P = 0.041). Lenalidomide maintenance therapy was underutilized in patients with synchronous malignancies, reflecting possible clinical hesitation. Myeloma-related mortality occurred in 17.1% of patients, with a median overall survival of 48 months (range: 16-80), and no significant survival difference between synchronous and patient with prior solid tumor history group. CONCLUSION: The presence of synchronous solid tumors in NDMM patients is associated with a higher rate of extramedullary disease and may influence clinical decision-making, highlighting the need for multidisciplinary management and individualized treatment strategies. Furthermore, extramedullary involvement in MM should prompt evaluation for a potential coexisting solid malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Hematology, Gaziantep City Hospital, Gaziantep, Turkey. Electronic address: yasagulmutlu@hotmail.com.
- Department of Hematology, Erciyes University, Kayseri, Turkey.
- Department of Hematology, Cerrahpasa University, Istanbul, Turkey.
- Department of Hematology, University of Health Sciences, Istanbul Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
- University of Health Sciences Türkiye, İstanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital, Clinic of Hematology, İstanbul, Türkiye.
- Department of Hematology, Ankara University, Ankara, Turkey.
Zitieren
APA
Mutlu, Y. G., Emre Ünsal, Ş., Güleç, B., Serin, İ., Arslan Davulcu, E., Sönmez, G. M., Güven, S., Yiğit Kaya, S., Maral, S., Keklik, M., Salihoğlu, A., Cetintepe, T., Cengiz Seval, G., & Sevindik, Ö. G. (2026). The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2025.10.006
Vancouver
Mutlu YG, Emre Ünsal Ş, Güleç B, Serin İ, Arslan Davulcu E, Sönmez GM, et al. The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History. Clinical Lymphoma Myeloma and Leukemia. 2026. doi:10.1016/j.clml.2025.10.006
BibTeX
@article{Mutlu2026,
author = {Mutlu, Yaşa Gül and Emre Ünsal, Şerife and Güleç, Buse and Serin, İstemi and Arslan Davulcu, Eren and Sönmez, Gülçin Miyase and Güven, Serkan and Yiğit Kaya, Süreyya and Maral, Senem and Keklik, Muzaffer and Salihoğlu, Ayşe and Cetintepe, Tugba and Cengiz Seval, Güldane and Sevindik, Ömür Gökmen},
title = {The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2026},
doi = {10.1016/j.clml.2025.10.006}
}
EUVIMED